depression news from FierceBioResearcher
News
New drug class could have wide health impact
Vaptans are a new class of drug that target a wide variety of conditions by inhibiting vasopressin, which regulates the circulatory system. Among the new drugs in development are relcovaptan, which Read more...
Compounds that rev up SSRI drugs
A researcher has identified a method for boosting the activity of antidepression drugs--an advance that could revolutionize the way these therapies work. Huge amounts of Read more...
Controlling brain protein may modulate stress, mood
New research has shed fresh light on the role of the brain protein deltaFosB in combating depression and various emotional disorders. A team of scientists at UT Southwestern exposed mice to random Read more...
Get more depression coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight